Mitsubishi UFJ Asset Management
LEGN icon

Mitsubishi UFJ Asset Management’s Legend Biotech LEGN Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
97,113
+332
+0.3% +$8.96K ﹤0.01% 734
2026
Q1 		$1.75M Buy
96,781
+21,703
+29% +$414K ﹤0.01% 743
2025
Q4 		$1.61M Buy
75,078
+312
+0.4% +$8.94K ﹤0.01% 768
2025
Q3 		$2.44M Buy
74,766
+15
+0% +$554 ﹤0.01% 720
2025
Q2 		$2.65M Buy
74,751
+19,141
+34% +$620K ﹤0.01% 712
2025
Q1 		$1.89M Buy
55,610
+579
+1% +$20.8K ﹤0.01% 740
2024
Q4 		$1.97M Buy
55,031
+207
+0.4% +$8.57K ﹤0.01% 744
2024
Q3 		$2.67M Sell
54,824
-578
-1% -$30.8K ﹤0.01% 708
2024
Q2 		$2.45M Buy
55,402
+2,818
+5% +$130K ﹤0.01% 706
2024
Q1 		$2.95M Buy
52,584
+9,122
+21% +$550K ﹤0.01% 696
2023
Q4 		$2.52M Buy
43,462
+7,093
+20% +$449K ﹤0.01% 699
2023
Q3 		$2.44M Buy
36,369
+5,040
+16% +$350K ﹤0.01% 705
2023
Q2 		$2.16M Sell
31,329
-1,496
-5% -$97.8K ﹤0.01% 732
2023
Q1 		$1.58M Buy
32,825
+7,439
+29% +$364K ﹤0.01% 760
2022
Q4 		$1.24M Sell
25,386
-991
-4% -$48K ﹤0.01% 783
2022
Q3 		$1.08M Buy
26,377
+121
+0.5% +$5.68K ﹤0.01% 787
2022
Q2 		$1.44M Buy
26,256
+387
+1% +$16.3K 0.01% 758
2022
Q1 		$940K Buy
25,869
+11,326
+78% +$448K ﹤0.01% 841
2021
Q4 		$701K Buy
14,543
+6,048
+71% +$307K ﹤0.01% 903
2021
Q3 		$430K Hold
8,495
– – ﹤0.01% 961
2021
Q2 		$349K Buy
+8,495
New +$289K ﹤0.01% 1010

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Mitsubishi UFJ Asset Management's LEGN Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Legend Biotech (LEGN) stake by 0.34% in Q2 2026, buying an estimated $8.96K and bringing the position to 97,113 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Mitsubishi UFJ Asset Management first reported a position in LEGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.95M in Q1 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 97,113 shares of Legend Biotech worth $2.8M as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 332 Legend Biotech shares in Q2 2026, an estimated $8.96K.
  • Legend Biotech made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #734 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Legend Biotech in Q2 2021 and has held it in 21 quarters since.
  • Mitsubishi UFJ Asset Management's Legend Biotech position peaked at $2.95M in Q1 2024.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.